Genetically modified immunocompetent cells in HIV infection

G. Palù, G. Li Pira, F. Gennari, D. Fenoglio, C. Parolin, F. Manca

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Even in the era of highly active antiretroviral therapy (HAART), gene therapy (GT) can remain a promising approach for suppressing HIV infection, especially if complemented with other forms of pharmacological and immunological intervention. A large number of vectors and targets have been studied. Here we discuss the potential of genetically treated, antigen-specific immunocompetent cells for adoptive autologous immunotherapy of HIV infection. Cellular therapies with gene-modified CD8 and CD4 lymphocytes are aimed at reconstituting the antigen-specific repertoires that may be deranged as a consequence of HIV infection. Even if complete eradication of HIV from the reservoirs cannot be achieved, reconstitution of cellular immunity specific for opportunistic pathogens and for HIV itself is a desirable option to control progression of HIV infection and AIDS pathogenesis better.

Original languageEnglish
Pages (from-to)1593-1600
Number of pages8
JournalGene Therapy
Volume8
Issue number21
DOIs
Publication statusPublished - 2001

Fingerprint

HIV Infections
Genetic Therapy
HIV
Adoptive Immunotherapy
Antigens
Highly Active Antiretroviral Therapy
Cellular Immunity
Acquired Immunodeficiency Syndrome
Pharmacology
Lymphocytes

Keywords

  • Cell therapy
  • Gene therapy
  • HIV
  • Immunoreconstitution
  • Opportunistic pathogens
  • T cell repertoire

ASJC Scopus subject areas

  • Genetics

Cite this

Genetically modified immunocompetent cells in HIV infection. / Palù, G.; Pira, G. Li; Gennari, F.; Fenoglio, D.; Parolin, C.; Manca, F.

In: Gene Therapy, Vol. 8, No. 21, 2001, p. 1593-1600.

Research output: Contribution to journalArticle

Palù, G. ; Pira, G. Li ; Gennari, F. ; Fenoglio, D. ; Parolin, C. ; Manca, F. / Genetically modified immunocompetent cells in HIV infection. In: Gene Therapy. 2001 ; Vol. 8, No. 21. pp. 1593-1600.
@article{9b7473bf8197417daa353fba54ddbdad,
title = "Genetically modified immunocompetent cells in HIV infection",
abstract = "Even in the era of highly active antiretroviral therapy (HAART), gene therapy (GT) can remain a promising approach for suppressing HIV infection, especially if complemented with other forms of pharmacological and immunological intervention. A large number of vectors and targets have been studied. Here we discuss the potential of genetically treated, antigen-specific immunocompetent cells for adoptive autologous immunotherapy of HIV infection. Cellular therapies with gene-modified CD8 and CD4 lymphocytes are aimed at reconstituting the antigen-specific repertoires that may be deranged as a consequence of HIV infection. Even if complete eradication of HIV from the reservoirs cannot be achieved, reconstitution of cellular immunity specific for opportunistic pathogens and for HIV itself is a desirable option to control progression of HIV infection and AIDS pathogenesis better.",
keywords = "Cell therapy, Gene therapy, HIV, Immunoreconstitution, Opportunistic pathogens, T cell repertoire",
author = "G. Pal{\`u} and Pira, {G. Li} and F. Gennari and D. Fenoglio and C. Parolin and F. Manca",
year = "2001",
doi = "10.1038/sj.gt.3301569",
language = "English",
volume = "8",
pages = "1593--1600",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "21",

}

TY - JOUR

T1 - Genetically modified immunocompetent cells in HIV infection

AU - Palù, G.

AU - Pira, G. Li

AU - Gennari, F.

AU - Fenoglio, D.

AU - Parolin, C.

AU - Manca, F.

PY - 2001

Y1 - 2001

N2 - Even in the era of highly active antiretroviral therapy (HAART), gene therapy (GT) can remain a promising approach for suppressing HIV infection, especially if complemented with other forms of pharmacological and immunological intervention. A large number of vectors and targets have been studied. Here we discuss the potential of genetically treated, antigen-specific immunocompetent cells for adoptive autologous immunotherapy of HIV infection. Cellular therapies with gene-modified CD8 and CD4 lymphocytes are aimed at reconstituting the antigen-specific repertoires that may be deranged as a consequence of HIV infection. Even if complete eradication of HIV from the reservoirs cannot be achieved, reconstitution of cellular immunity specific for opportunistic pathogens and for HIV itself is a desirable option to control progression of HIV infection and AIDS pathogenesis better.

AB - Even in the era of highly active antiretroviral therapy (HAART), gene therapy (GT) can remain a promising approach for suppressing HIV infection, especially if complemented with other forms of pharmacological and immunological intervention. A large number of vectors and targets have been studied. Here we discuss the potential of genetically treated, antigen-specific immunocompetent cells for adoptive autologous immunotherapy of HIV infection. Cellular therapies with gene-modified CD8 and CD4 lymphocytes are aimed at reconstituting the antigen-specific repertoires that may be deranged as a consequence of HIV infection. Even if complete eradication of HIV from the reservoirs cannot be achieved, reconstitution of cellular immunity specific for opportunistic pathogens and for HIV itself is a desirable option to control progression of HIV infection and AIDS pathogenesis better.

KW - Cell therapy

KW - Gene therapy

KW - HIV

KW - Immunoreconstitution

KW - Opportunistic pathogens

KW - T cell repertoire

UR - http://www.scopus.com/inward/record.url?scp=0035186203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035186203&partnerID=8YFLogxK

U2 - 10.1038/sj.gt.3301569

DO - 10.1038/sj.gt.3301569

M3 - Article

VL - 8

SP - 1593

EP - 1600

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 21

ER -